These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17155850)

  • 1. Novel inhibitors of the early steps of the HIV-1 life cycle.
    Citterio P; Rusconi S
    Expert Opin Investig Drugs; 2007 Jan; 16(1):11-23. PubMed ID: 17155850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New advances in HIV entry inhibitors development.
    Rusconi S; Scozzafava A; Mastrolorenzo A; Supuran CT
    Curr Drug Targets Infect Disord; 2004 Dec; 4(4):339-55. PubMed ID: 15578975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update in the development of HIV entry inhibitors.
    Rusconi S; Scozzafava A; Mastrolorenzo A; Supuran CT
    Curr Top Med Chem; 2007; 7(13):1273-89. PubMed ID: 17627557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The promise of CCR5 antagonists as new therapies for HIV-1.
    Repik A; Richards KH; Clapham PR
    Curr Opin Investig Drugs; 2007 Feb; 8(2):130-9. PubMed ID: 17328229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HIV entry inhibitors revisited.
    Leonard JT; Roy K
    Curr Med Chem; 2006; 13(8):911-34. PubMed ID: 16611075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV co-receptors as targets for antiviral therapy.
    Schols D
    Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral CCR5 inhibitors: will they make it through?
    Biswas P; Nozza S; Scarlatti G; Lazzarin A; Tambussi G
    Expert Opin Investig Drugs; 2006 May; 15(5):451-64. PubMed ID: 16634684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CXCR4 in HIV cell-entry inhibition.
    Steen A; Schwartz TW; Rosenkilde MM
    Mini Rev Med Chem; 2009 Dec; 9(14):1605-21. PubMed ID: 20088780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV/AIDS: recent advances in antiretroviral agents.
    Nikolopoulos G; Bonovas S; Tsantes A; Sitaras NM
    Mini Rev Med Chem; 2009 Jul; 9(8):900-10. PubMed ID: 19601885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs.
    Seibert C; Sakmar TP
    Curr Pharm Des; 2004; 10(17):2041-62. PubMed ID: 15279544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 entry inhibitors: an overview.
    Kuritzkes DR
    Curr Opin HIV AIDS; 2009 Mar; 4(2):82-7. PubMed ID: 19339945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-receptor antagonists as HIV-1 entry inhibitors.
    Shaheen F; Collman RG
    Curr Opin Infect Dis; 2004 Feb; 17(1):7-16. PubMed ID: 15090884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pouncing on the chemokine receptor Chimera.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):13-24. PubMed ID: 11364629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 coreceptors and their inhibitors.
    Ray N; Doms RW
    Curr Top Microbiol Immunol; 2006; 303():97-120. PubMed ID: 16570858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic coreceptor analysis.
    Sierra S; Kaiser R; Thielen A; Lengauer T
    Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.
    Panos G; Watson DC
    Crit Rev Microbiol; 2015; 41(4):473-87. PubMed ID: 24635642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine receptor-directed agents as novel anti-HIV-1 therapies.
    Mills SG; DeMartino JA
    Curr Top Med Chem; 2004; 4(10):1017-33. PubMed ID: 15193136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
    Princen K; Schols D
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.
    De Clercq E; Schols D
    Antivir Chem Chemother; 2001; 12 Suppl 1():19-31. PubMed ID: 11594685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR5 antagonists: a new tool in fighting HIV.
    Jülg B; Goebel FD
    J HIV Ther; 2005 Dec; 10(4):68-71. PubMed ID: 16519245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.